Author:
Paterson I. A.,Davis B. A.,Durden D. A.,Juorio A. V.,Yu P. H.,Ivy G.,Milgram W.,Mendonca A.,Wu P.,Boulton A. A.
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine,Biochemistry
Reference44 articles.
1. Marsden, C. D. 1990. Parkinson's disease. Lancet 335:948?952.
2. Fowler, C. J., O'Carroll, A.-M., and Tipton, K. F. 1984. Deamination of dopamine by monoamine oxidase-A and-B in the rat and in man. Pages 393?402,in K. F. Tipton, P. Dostert, and M. Strolin Benedetti, (eds.) Monoamine oxidase and disease: prospects for therapy with reversible inhibitors, Academic Press Inc.: London.
3. Garrick, N. A., and Murphy, D. L. 1980. Species differences in the deamination of dopamine and other substrates for monamine oxidase in brain. Psychopharmacology 72:27?33.
4. Fowler, C. J., Oreland, L., Marcusson, J., and Winblad, B. 1980. Titration of human brain monoamine oxidase-A and-B by clorgyline and 1-deprenyl. Naunyn-Schmeideberg's Archives of Pharmacology 311:263?272.
5. Major, L. F., Murphy, D. L., Lipper, S., and Gordon, E. 1979. Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid. J. Neurochem. 32:229?231.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献